跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GLIOTEM 20 CAPSULE 20 MG - HSA Drug Approval Details
Approvals
/
HSA
/
GLIOTEM 20 CAPSULE 20 MG
Approved
THERAPEUTIC
GLIOTEM 20 CAPSULE 20 MG
SUN PHARMACEUTICAL INDUSTRIES LIMITED. (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Mar 1, 2019
Approval ID
b5a36bf483be141a
Company
SUN PHARMACEUTICAL INDUSTRIES LIMITED. (INDIA)
Type
Therapeutic
Approval Details
Approval Id
b5a36bf483be141a
Drug Name
GLIOTEM 20 CAPSULE 20 MG
Product Name
GLIOTEM 20 CAPSULE 20 MG
Approval Number
SIN15641P
Approval Date
2019-03-01
Registrant
RANBAXY (MALAYSIA) SDN. BHD.
Licence Holder
RANBAXY (MALAYSIA) SDN. BHD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
CAPSULE
Route Of Administration
ORAL
Atc Code
L01AX03
Atc Item Name
temozolomide
Pharma Manufacturer Name
RANBAXY (MALAYSIA) SDN. BHD.
Company Detail Path
/organization/ranbaxy-malaysia-sdn-bhd
Active Ingredients
Temozolomide
20.000 mg
TEMOZOLOMIDE
20 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 1, 2019
Approval ID
b5a36bf483be141a
Type
Therapeutic
Back to HSA Approvals